Investors will watch for market reaction to an overnight report by the Financial Times — citing documents accidentally published by the World Health Organization — that Gilead Sciences' drug remdesivir did not improve coronavirus patients' condition. The documents cited by the FT referred to a Chinese clinical trial.
Stocks in Japan were set to decline at the Friday open after an overnight report that raised doubts over a potential coronavirus treatment. The Nikkei futures contract in Chicago was at 19,385 while its counterpart in Osaka was at 19,370. That compared against theMeanwhile, shares in Australia were poised for a muted open, with the SPI futures contract at 5,218, as compared to the S&P/ASX 200's last close at 5,217.10.
Why would anyone believe anything coming out of the WHO?